 long-term efficaci oral cisaprid symptomat upper gut dysmotil trial cisaprid mg time day patient gastric stasi due gastroparesi due diabet chronic intestin pseudo-obstruct radionuclid solid-liquid gastric test baselin end period symptom diari month investig frequenc sever symptom standard manner whole group patient gastric empti solid liquid year cisaprid chronic intestin pseudoobstruct patient improv gastric empti solid contrast patient gastroparesi improv liquid empti total symptom score gastroparesi group median score baselin vs year chronic intestin pseudoobstruct patient median score baselin vs year bodi trend toward improv gastroparesi group signific side effect open trial cisaprid effect gastric patient gastric stasi symptom gastroparesi